Investor centre
Share price
66.00 GBX
LON: REDX
28/11/2021
10:56:35 PM
Latest news
-
17-Nov-2021 Redx to Present at Jefferies London Healthcare Conference
-
15-Nov-2021 Redx Announces First Patient Dosed in Phase 2 Clinical Trial of RXC004 in Patients with Advanced Colorectal Cancer
Featured webcasts
View all66.00 GBX
LON: REDX
28/11/2021
10:56:35 PM
Latest documents
Analyst reports
-
12-Oct-2021 Trinity Delta – R&D update: RXC004 and RXC007 in the spotlight
-
21-Sep-2021 New Trinity Delta Research Report – ESMO 2021: RXC004 monotherapy Phase I study results
-
07-Sep-2021 New Trinity Delta Research Report – ‘All that Jazz: $3m milestone boosts cash and confidence’
-
27-Jul-2021 New Trinity Delta Research Report – RXC004 2mg dose selected for Phase II trials
Investor FAQs
1. Where is the Company’s registered office?
Block 33, Mereside, Alderley Park, Macclesfield SK10 4TG
2. How can I contact the company?
Please email us at info@redxpharma.com
3. What is the Company’s financial year end?
Our financial year ends on 30 September
4. Are the company’s shares listed?
Yes, our shares are listed on the AIM market. Operated by the London Stock Exchange.
5. How can I stay up to date with Company news?
Our website is updated frequently, and you can register for email alerts from within the investors section of our website.
